Literature DB >> 4017307

An animal model to study serum immunoglobulin response to infection by Yersinia enterocolitica.

D H Kono, M Ogasawara, D T Yu.   

Abstract

Using an Elisa method, we tested whether the serum immunoglobulin response of CBA/H mice, orally infected by a serotype 03 strain of Yersinia enterocolitica was of sufficient magnitude to serve as an experimental model. We found that the dose of bacteria administered was important. At a dose of 10(10)-10(12) bacteria per mouse, easily detectable IgM, IgG and IgA antibody titers could be obtained. At 10(8) bacteria per mouse, although diarrhea occurred and Yersinia was shed into the stool, the antibody titers were minimal.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4017307

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  4 in total

1.  Rational live oral carrier vaccine design by mutating virulence-associated genes of Yersinia enterocolitica.

Authors:  E I Igwe; H Rüssmann; A Roggenkamp; A Noll; I B Autenrieth; J Heesemann
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

2.  Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon.

Authors:  I B Autenrieth; M Beer; E Bohn; S H Kaufmann; J Heesemann
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

3.  Susceptibility of four inbred mouse strains to a low-pathogenic isolate of Yersinia enterocolitica.

Authors:  Angela Schippers; Silke Mateika; Blair Prochnow; Achim D Gruber; Werner Müller; Ursula Frischmann
Journal:  Mamm Genome       Date:  2008-04-05       Impact factor: 2.957

4.  Experimental Yersinia enterocolitica infection in euthymic and T-cell-deficient athymic nude C57BL/6 mice: comparison of time course, histomorphology, and immune response.

Authors:  I B Autenrieth; U Vogel; S Preger; B Heymer; J Heesemann
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.